EMEA-001579-PIP01-13-M02

Key facts

Invented name
Truberzi
Active substance
eluxadoline
Therapeutic area
Gastroentology-Hepatology
Decision number
P/0388/2017
PIP number
EMEA-001579-PIP01-13-M02
Pharmaceutical form(s)
  • Film-coated tablet
  • Age-appropriate oral liquid
Condition(s) / indication(s)
Treatment of diarrhoea-predominant irritable bowel Syndrome
Route(s) of administration
Oral use
Contact for public enquiries
Allergan Pharmaceuticals International Limited

Tel. +44 (0) 1628 4944444
E-mail: ml-eu_reg_affairs@allergan.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating